Clinical trial
A Crossover Intervention Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis Patients
NCT00550693 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Crossover Intervention Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis Patients
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2004
- Completion date
- March 31, 2005
- Enrollment
- 121 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
catheter related bloodstream infection